Extraordinary Measures for Egyptian Children With Hemato-Oncological Disorders During COVID-19 Pandemic

  • participants needed
  • sponsor
    Fatma Soliman Elsayed Ebeid
Updated on 8 August 2022


This is a prospective follow-up non-intervention study that will be carried out at Hematology/ Oncology Department, Children's hospital, Ain-Shams University, Cairo, Egypt. All followed-up children below 18 years with cancer during the one year study period from May 2020 till Apr 2021 either at the out-patients clinic or inpatient department will be recruited.


Study Procedures:

On admission or during the outpatient visit:

  1. Obtaining an informed consent .
  2. Full medical history, concurrent medications, demographic data and epidemiological data (history of contact to a COVID-19 case, history of travel), will be obtained.
  3. A thorough physical examination will be performed.
  4. Body weight, height, BMI, vital signs (blood pressure, heart rate and temperature) and blood oxygen saturation) will be recorded.
  5. Laboratory to perform the following tests:

Complete blood count with differential counts, COVID -19 reverse Transcription Polymerase Chain Reaction (RT-PCR) test by nasopharyngeal swab.

During admission:

Whenever unexplained fever and or respiratory symptoms developed or whenever COVID19 suspected to have the following to be performed:

  1. Symptom developed that necessitates to repeat oropharyngeal and nasopharyngeal swab if indicated will be collected
  2. Chest X-ray or CT chest will be recorded.
  3. Laboratory to perform the following tests:

Complete blood count with differential counts,

COVID-19 RT-PCR test by oropharyngeal and nasopharyngeal swab:

C-reactive protein and serum ferritin level. Coagulation test; D. dimer, prothrombin time and INR. Routine bacteriological study, blood culture and other symptoms/signs based cultures will be recorded

On discharge:

  • Date of discharge
  • Period of admission
  • Period of fever
  • A thorough physical examination will be performed
  • Record the outcome

Condition Coronavirus COVID-19, Coronavirus COVID-19, Coronavirus COVID-19, Coronavirus COVID-19, Coronavirus COVID-19
Clinical Study IdentifierNCT04404244
SponsorFatma Soliman Elsayed Ebeid
Last Modified on8 August 2022

Similar trials to consider


Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note